Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clio P Mavragani

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Annual Review of Medicine|January 19, 2017
Mechanisms and New Strategies for Primary Sjögren's SyndromeClio P Mavragani
Journal of Immunology Research|November 10, 2015
Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related LymphomagenesisAdrianos Nezos, Clio P Mavragani
Journal of Autoimmunity|June 14, 2017
Cardiovascular disease in systemic lupus erythematosus: A comprehensive updateMayra Giannelou, Clio P Mavragani
Mediterranean Journal of Rheumatology|November 9, 2023
Prevalence and Clinical Implications of Scleroderma-Specific Autoantibodies in Seronegative Patients with Sicca ComplaintsNikolaos Marketos, Clio P Mavragani
Clinical Rheumatology|December 21, 2005
Retroperitoneal fibrosis and c-ANCA positivityClio P Mavragani, Michalis Voulgarelis
Journal of Autoimmunity|December 14, 2019
Sjögren's syndrome: Old and new therapeutic targetsClio P Mavragani, Haralampos M Moutsopoulos
Annual Review of Pathology|September 21, 2013
Sjögren's syndromeClio P Mavragani, Haralampos M Moutsopoulos
Clinical Immunology (Orlando, Fla.)|June 13, 2020
Sicca syndrome following immune checkpoint inhibitionClio P Mavragani, Haralampos M Moutsopoulos
Current Opinion in Rheumatology|July 16, 2011
Activation of the type I interferon pathway in primary Sjögren's syndrome: an updateKaterina M Vakaloglou, Clio P Mavragani
Clinical Reviews in Allergy & Immunology|November 10, 2007
Conventional therapy of Sjogren's syndromeClio P Mavragani, Haralampos M Moutsopoulos
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Annual Review of Medicine|January 19, 2017
Mechanisms and New Strategies for Primary Sjögren's SyndromeClio P Mavragani
Journal of Immunology Research|November 10, 2015
Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related LymphomagenesisAdrianos Nezos, Clio P Mavragani
Journal of Autoimmunity|June 14, 2017
Cardiovascular disease in systemic lupus erythematosus: A comprehensive updateMayra Giannelou, Clio P Mavragani
Mediterranean Journal of Rheumatology|November 9, 2023
Prevalence and Clinical Implications of Scleroderma-Specific Autoantibodies in Seronegative Patients with Sicca ComplaintsNikolaos Marketos, Clio P Mavragani
Clinical Rheumatology|December 21, 2005
Retroperitoneal fibrosis and c-ANCA positivityClio P Mavragani, Michalis Voulgarelis
Journal of Autoimmunity|December 14, 2019
Sjögren's syndrome: Old and new therapeutic targetsClio P Mavragani, Haralampos M Moutsopoulos
Annual Review of Pathology|September 21, 2013
Sjögren's syndromeClio P Mavragani, Haralampos M Moutsopoulos
Clinical Immunology (Orlando, Fla.)|June 13, 2020
Sicca syndrome following immune checkpoint inhibitionClio P Mavragani, Haralampos M Moutsopoulos
Current Opinion in Rheumatology|July 16, 2011
Activation of the type I interferon pathway in primary Sjögren's syndrome: an updateKaterina M Vakaloglou, Clio P Mavragani
Clinical Reviews in Allergy & Immunology|November 10, 2007
Conventional therapy of Sjogren's syndromeClio P Mavragani, Haralampos M Moutsopoulos
Pageof 12